NIH-funded research NIH-funded research

Liver Cancer Early Detection Program: Data & Coordination Center for Biomarker Research

Official title: Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC)

Funded at Fred Hutchinson Cancer Center · NIH-11406291 · Data updated 2026-11-12

A national group coordinates data, biobanks, and biomarker research to improve early detection of liver cancer in people with cirrhosis.

More Liver Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionFred Hutchinson Cancer Center
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 17, 2018
Project endAugust 31, 2028
Funding year2026
Award (this year)$820,192
NIH project number5U24CA230144-10
Project IDNIH-11406291 on NIH RePORTER

Who could benefit from this research

Could help

Adults with cirrhosis or at high risk for liver cancer who may participate in future biomarker studies or data sharing efforts.

Less likely to help

People not at risk for liver cancer or not involved in biomarker studies may not directly benefit.

What this research studies

This grant funds a centralized hub that connects researchers, manages data and biorepositories, and provides statistical support to advance early detection of liver cancer. It focuses on standardizing study protocols, enabling collaboration, and validating promising biomarkers for better surveillance in high-risk patients. The center will maintain secure databases, coordinate across institutions, and facilitate multi-site studies to move promising findings toward clinical use. Patients with liver cirrhosis could ultimately benefit from more accurate, timely screening informed by this coordinated effort.

Why it matters

Potential benefit: If successful, this project could lead to earlier detection of liver cancer and improved risk stratification for people with cirrhosis, potentially improving survival.

How similar studies have gone: Similar multi-center biomarker efforts have shown promise in cancer early detection, though this project emphasizes data coordination and validation across a liver cancer consortium.

Where this research is happening

  • Fred Hutchinson Cancer Center
    Seattle, United States
    Active

Researchers

  • Principal investigator: Feng, Ziding — Fred Hutchinson Cancer Center
  • Study coordinator: Feng, Ziding

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.